Henrik Moebitz

618 total citations
8 papers, 441 citations indexed

About

Henrik Moebitz is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Henrik Moebitz has authored 8 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Henrik Moebitz's work include Melanoma and MAPK Pathways (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Henrik Moebitz is often cited by papers focused on Melanoma and MAPK Pathways (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Henrik Moebitz collaborates with scholars based in Switzerland, United States and Norway. Henrik Moebitz's co-authors include Doriano Fabbro, Sandra W. Cowan‐Jacob, Richard Heng, Roland Feifel, Guido Koch, Clemens Scheufler, Christine Huppertz, Achim Schlapbach, Stuart Hawtin and Láśzló Révész and has published in prestigious journals such as British Journal of Pharmacology, European Journal of Medicinal Chemistry and Cancer Discovery.

In The Last Decade

Henrik Moebitz

7 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henrik Moebitz Switzerland	5	325	119	105	58	54	8	441
Jason Boggs United States	10	441 1.4×	145 1.2×	74 0.7×	59 1.0×	64 1.2×	15	572
Amy M. Delaney United States	7	292 0.9×	90 0.8×	83 0.8×	33 0.6×	54 1.0×	8	441
Min‐Wu Chao Taiwan	15	364 1.1×	149 1.3×	86 0.8×	46 0.8×	31 0.6×	26	492
Brian Zifcak United States	7	431 1.3×	136 1.1×	125 1.2×	51 0.9×	31 0.6×	10	570
Laurie S. Kane-Carson United States	6	326 1.0×	177 1.5×	135 1.3×	102 1.8×	67 1.2×	8	481
Camilo Quevedo United Kingdom	9	312 1.0×	87 0.7×	89 0.8×	27 0.5×	36 0.7×	11	430
Jim Nonomiya United States	13	390 1.2×	127 1.1×	127 1.2×	72 1.2×	36 0.7×	18	659
Marc R. Arnone United States	7	474 1.5×	201 1.7×	113 1.1×	122 2.1×	70 1.3×	7	620
Mari Ikuta Japan	8	322 1.0×	169 1.4×	215 2.0×	96 1.7×	57 1.1×	8	541
Randy Hoffman United States	5	544 1.7×	103 0.9×	102 1.0×	114 2.0×	58 1.1×	6	678

Countries citing papers authored by Henrik Moebitz

Since Specialization

Citations

This map shows the geographic impact of Henrik Moebitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Moebitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Moebitz more than expected).

Fields of papers citing papers by Henrik Moebitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Moebitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Moebitz. The network helps show where Henrik Moebitz may publish in the future.

Co-authorship network of co-authors of Henrik Moebitz

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Moebitz. A scholar is included among the top collaborators of Henrik Moebitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Moebitz. Henrik Moebitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Dittrich, Birger, et al.. (2025). Benchmarking quantum chemical methods with X-ray structures via structure-specific restraints. IUCrJ. 12(4). 472–487.

2.

Gao, Yijun, Matthew T. Chang, Daniel J. McKay, et al.. (2018). Allele-Specific Mechanisms of Activation of MEK1 Mutants Determine Their Properties. Cancer Discovery. 8(5). 648–661. 87 indexed citations

3.

Fabbro, Doriano, Sandra W. Cowan‐Jacob, & Henrik Moebitz. (2015). Ten things you should know about protein kinases: IUPHAR R eview 14. British Journal of Pharmacology. 172(11). 2675–2700. 265 indexed citations

4.

Martin, Éric, Stefan Knapp, Richard A. Engh, et al.. (2015). Perspective on computational and structural aspects of kinase discovery from IPK2014. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1854(10). 1595–1604. 4 indexed citations

5.

Berst, Frédéric, Andreas L. Marzinzik, Henrik Moebitz, et al.. (2012). The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: A proof-of-concept study. European Journal of Medicinal Chemistry. 57. 1–9. 14 indexed citations

6.

Berst, Frédéric, Andreas L. Marzinzik, Henrik Moebitz, et al.. (2011). Substrate profiling of IGF-1R and InsR: Identification of a potent pentamer substrate. Bioorganic & Medicinal Chemistry Letters. 21(23). 7030–7033. 1 indexed citations

7.

Velcicky, Juraj, Roland Feifel, Stuart Hawtin, et al.. (2009). Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy. Bioorganic & Medicinal Chemistry Letters. 20(3). 1293–1297. 35 indexed citations

8.

Schlapbach, Achim, Roland Feifel, Stuart Hawtin, et al.. (2008). Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity. Bioorganic & Medicinal Chemistry Letters. 18(23). 6142–6146. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact